Materiality

Material Issue Identification Process

11 material issues identified

We have identified 11 "material issues" from the perspective of relevance to our business and social contribution.
We recognize “contribution to women’s health” and “contribution to animal health” as distinctive material issues for the Company.
ASKA Pharmaceutical Holdings group will work on each issue and contribute to the achievement of SDGs.

Company-wide Action Plan and KPIs for Material Issues

ESG Material Issues Company-wide Action Plan KPIs SDGs
E Environmental protection and continuous reduction of environmental impact Environmental protection, continuous reduction of environmental impact, and promotion of environmental management 1. Reduction of CO2 emissions: Reduction of 46% from FY2013 (FY2030)
2. Reduction of total waste
3. Improvement in recycling rates
4. Promotion of environmental measures
5. Environmentally conscious business operations
6. Reduction of the use of natural resources
7. Reduction of emissions of environmentally harmful substances (reduction of the impact of nitrogen on the environment by promoting low-protein feed)
S Human resource development Development of human resources to realize growth strategies 1. Number of in-house recruitment system and interdepartmental transfers
(number of career challenges)
2. Number of elective training courses taken: Next-generation leader training Number of selective  training courses taken: Training to promote the advancement of women (career development of female employees)/other selective training as a measure to support the autonomous learning of employees Expenditures per employee (for education)
3. Promote the implementation of internal and external hierarchical training/selective training (career development of female employees)
Employee engagement Creation of an environment that promotes understanding of the organization, sympathy, and motivation to take action, and achievement of work-life balance that respects the health and diversity of our employees 1. Optimization of working hours: Promotion of the use of annual paid leave as planned, guidance for promotion of the use of annual leave, provision of annual leave (taken hourly), etc.
2. Health management initiatives
3. Promotion of various working styles: telecommunicating, telework, flextime, short-time work, etc.
4. Implementation of regular stress checks and surveys for engagement
5. Promotion of women’s advancement in active roles (FY2024 target): Percentage of female managers (15%)
Percentage of female medical representatives (20%)
6. Promotion of active roles for diverse human resources
7. Measures to support development of the next generation: Maternity leave
 (utilization rate 100%) / Childcare leave for male employees (utilization rate 100%)
8. Support for medical representatives to take maternity leave and childcare leave (implementation of reintegration programs, social gatherings, etc.)
Creation of innovative products Expansion of pipeline through open innovation 1. Promotion of in-house research themes
2. Reinforcement of alliance activities
Expanding access to healthcare Contributions to specialty areas by taking advantage of our own strengths 1. Provision of comprehensive information on specialty areas (Ob/Gyn, thyroid)
2. Promotion of accurate information and raising disease awareness
3. Early identification of diseases through activities to promote testing and diagnostics
4. Early detection of disease through non-invasive measurement kit
Contribution to women’s health Total support for women’s health 1. Contribution to women’s healthcare by providing products for each of women’s life stages
2. New initiatives for women’s healthcare
3. Promotion of the advancement of women through activities to raise awareness on health and diseases
4. Sexual education initiatives for younger generation
5. Activities to raise awareness among families and partners about women’s health issues
Contribution to animal health Contribution to creation of a society where people and animals can coexist 1. Promotion of animal welfare
2. Development and provision of products useful for maintaining the health of companion animals
3. Development and provision of non-invasive measurement kit products using body hair
4. Promotion of biodiversity
Stable supply of high-quality products
Ensuring product quality and stable procurement and supply
1. Reinforcement of supply chain management
2. Implementation of appropriate GMP audits
3. Implementation of appropriate GQP (ensuring that a quality assurance system is in place)
Promotion of proper use of products Ensuring safety and providing information on proper use 1. Implementation of appropriate clinical trials (GCP compliance)
2. Adequate implementation of GVP and RMP
3. Compliance with GVP and guidelines for activities for provision of sales information
4. Dissemination of materials and knowledge to promote proper use, and strengthening product education for medical representatives, etc.
5. Prompt provision of latest information through website
G Corporate governance Establishment of corporate system for continuous growth 1. Fostering corporate culture and climate that respect healthy business ethics
2. Ensuring real equality of shareholders
3. Social contribution activities that lead to solving social issues
4. Constructive dialogue with stakeholders
5. Appropriate disclosure and explanation of management strategy, performance, financial condition, capital policy, etc.
Secure compliance with laws and regulations, enforcement of compliance Thorough maintenance of compliance and fostering an organizational climate that emphasizes reliability 1. Compliance system mainly promoted by Group Compliance Promotion Committee
2. Continuous implementation of preventive measures against serious incidents

Major Material Issue Initiatives Achievements

This section introduces the results of our efforts for material issue KPIs that are of particular interest to our stakeholders.
Our ESG Committee will oversee material issue initiatives and drive improvements.

E:  Environmental protection and continuous reduction of environmental impact
Company-wide Action Plan Environmental protection, continuous reduction of environmental impact, and promotion of environmental management
SDGs
KPIs 1st half of FY2023 activity report
Reduction of CO2 emissions: Reduction of 46% from FY2013 (FY2030)
  • CO2 emissions in the 1st half of FY2023 Total: 5,047[t-CO2] YOY 103%
  • Progress of solar power installation: construction was completed in October, and progress is on track for operation in April. ( planned to cover approx. 7% of the Iwaki Factory's electricity use).
  • The installation of heat pumps is currently under scrutiny.
  • Held company-wide energy management meeting and confirmed annual targets and mid- to long-term targets.
Reduction of total waste
  • Total amount of waste from the Iwaki Factory (2020: 128t, 2021: 153t, 2022: 137t ,first half of 2023: 88t)
  • Total annual waste volume is expected to increase this fiscal year due to increased production volume. We will work to reduce the amount of waste from non-performing assets (raw materials/finished products, etc.).
  • Crushed trees and other materials with crushers to reduce the amount of general waste generated.
  • Total amount of waste in the 1st half of 2023: 16.5 tons (36% of the planned annual waste amount of 45.9 tons for FY2023 submitted to Minato City)
Improvement in recycling rates
  • Recycling rate at Iwaki Factory: 2020: 67%, 2021: 58%, 2022: 79%, 1st half of 2023: approx. 93%
  • Recycling of metal is in progress. Conducted sequential recycling of machinery and other valuable resources related to the renovation of the No. 1 formulation building.
  • Head office: Percentage of waste to be recycled in the 1st half of 2023: 71.6% (11.8 tons recycled/16.5 tons of waste)
Promotion of environmental measures
  • Shonan Research Center's efforts:
    1. promotion of A/C night mode
  • 2. fluorocarbon inspection
  • 3. installation of air purifiers in each room/periodic cleaning (July) 
  • Full-scale activities for this year's ISO 14001 environmental management system started at the Iwaki Factory. Scheduled to conduct periodic external audits.
  • CO2 emissions were reduced (125t-CO2/year) by reducing utility costs associated with reduced product storage space due to the relocation of the warehouse to outside facilities.
  • Confirmed the report on the implementation of the FY2022 Mid-Term Environmental Plan and the FY2023-2025 Mid-Term Environmental Plan at the Company-Wide Environmental Management Meeting.。
  • Promoted the purchase of green products at the head office. Ratio of green products purchased: 44% (in the 1st half of 2023)
Environmentally conscious business operations
  • Shonan Research Center maintains a system for promoting environmental preservation, in accordance with the "Agreement on Environmental Preservation" between Fujisawa City/Kamakura City, which Shonan iPark has concluded. We also participated in the Environmental Conservation Committee/Energy Conservation Committee/Disaster Prevention Promotion Committee.
  • Selected environmentally friendly products such as green products for stationery purchases.
  • Reduced the number of transportation trucks by approximately 20% by moving to outside warehouses.
Reduction of the use of natural resources
  • Animal Health Initiatives
     1. Continuing to reduce the use of phosphorus ore, a natural resource, by marketing the feed additive Phytase.
     2. L-histidine hydrochloride was designated as a new feed additive. Expected to contribute to the reduction of fishmeal use in fish feed and to the conservation of natural fishmeal resources.
Reduction of emissions of environmentally harmful substances (reduction of the impact of nitrogen on the environment by promoting low-protein feed)
  • Animal Health Initiatives
    1. Promote low-protein feed by spreading the use of feed-use amino acids, and L-isoleucine was designated as a new feed additive.
    2. Promote L-isoleucine (LYS) to further lower the protein content of compound feeds.
S: Human resource development
Company-wide Action Plan Development of human resources to realize growth strategies
SDGs
  
KPIs 1st half of FY2023 activity report
Number of in-house recruitment system and interdepartmental transfers
(number of career challenges)
  • The internal recruitment in the second half of 2023 is to be publicly announced so that it can be reflected in the personnel changes effective April 1, 2024.
Number of elective training courses taken
: Next-generation leader training Number of selective training courses taken
: Training to promote the advancement of women (career development of female employees)/ other selective training as a measure to support the autonomous learning of employees Expenditures per employee (for education)
  • The following is a list of major training programs conducted during the fiscal year (the amount invested per employee will be reported at the end of the fiscal year)
    1. Elective training: "Next Generation Leader Training (Apple Program)" was conducted 2 times (15 participants). 
    2. Elective training: "Women's Self-Leadership Training" was conducted 1 time as career development for female employees (19 participants) 
    3. Selective training as a measure to support self-directed learning: "One-on-One Communication Training": Conducted 1 time (17 trainees)
    Logical thinking training: Conducted 1 time (17 participants) 
    4. Training for section managers (coaching training): Conducted 2 times (79 participants) 
    5. Leadership training for executives: Conducted 1 time (43 participants)
    6. Training for medical management specialists: Conducted 1 time (8 participants) 
    7. New employee induction training: Conducted in April-August (9 participants)
    8. Selective training (presentation training): Conducted 3 times (31 participants)
    9. Training for newly appointed executives: Conducted 1 time (3 participants)
    10. Training for career professionals: Coducted in April (2 participants)
    11. Sustainability training: Conducted 2 times in April and July.
  • Disseminated videos on ESG and material issues to all employees, promoting company-wide ESG management.
    (Attendance rate: 96.1%, Confirmation test correct answer rate: 84.3%)
Promote the implementation of internal and external level specific training/selective training (career development of female employees)
  • As a career development program for female employees, "Women's Self-Leadership Training" was conducted. The program provided an opportunity for female employees who "want to challenge management positions in the future" or "are wondering if they can take on such a challenge" to think about "what is their distinctive leadership style. On the day of the event, a panel session was held with board members and other female executives, who answered questions and provided advice to the participants.
S: Contribution to women’s health
Company-wide Action Plan
Total support for women’s health
SDGs
  
KPIs 1st half of FY2023 activity report
Contribution to women’s healthcare by providing products for each of women’s life stages
  • Initiatives of the Development Division: Progressed smoothly in clinical trials for the following gynecological development products in cooperation with the CRO and relevant departments.
  • 1. Ph III study of LF111 (oral contraceptive) progressed well.
    2. Initiated Ph I/II study of AKP-022 (uterine fibroids).
  • 3. Preparing to initiate TRM-270 Ph III study (gynecology).
  • Initiatives of the Business Development Division
  • 1. At the request of the Business Development Dept. and the Portfolio Management Dept., conducted a scientific assessment to expand product lineups for women's life stages.
    2. Signed a joint research and development agreement with SUSMED for a digital therapeutic app in the field of obstetrics and gynecology.
  • Launch of hair and nail cortisol measurement kit contributes to total support of women's health. 
New initiatives for women's healthcare
  • Proposed thyroid function tests for corporate health checkups.
  • As a Corporate Venture Capital (CVC) initiative, agreed to invest in one company from the ASKA Innovation Fund.
  • Started sales of "Training Videos on Women's Health"
    (New website "Mint⁺ Femknowledge" opened on October 3)
Promotion of the advancement of women through activities to raise awareness on health and diseases
  • The Japan Society for Occupational Health and the Comfortable Menstruation Project jointly held a luncheon seminar, "Dealing with Menstrual Problems as a Key to Improving Productivity in the Workplace.
    (More than 240 attendees at the venue, 226 live-streaming viewers, and 637 on-demand viewers).
    An article titled "Neglecting Women's Health Issues is Costly for Companies" was also published in Nikkei Medical Online and Nikkei Business (2 articles in total).
  • Articles on menstruation, women's bodies and health were published by Mint+.
Sexual education initiatives for younger generation
  • Sales Division: onducted web-based lectures for medical professionals on the treatment of adolescent dysmenorrhea and iron deficiency anemia (2 times). Also, exhibited information sharing materials for patients at the Contraception and STD Prevention Seminar for Instructors (SRH Seminar) (2 times, 200 attendees in total)
  • Mint⁺ teens: uploaded 2 articles on the correct way to cope with menstruation, mainly for high school students.
    We also posted 5 feeds on Instagram.
  • Mint⁺: Added the 2023 edition of the Health and Physical Education Supplementary Material for High School Students (PDF).
    (Booklets provided: 170,000 copies / 429 schools)
  • Online seminar "Aging in a wonderful way! Menopause and Women's Health" (1 time/July)
Activities to raise awareness among families and partners about women’s health issues
  • Human Resources Department: Plan and organize a study session for employees and their families as part of the knowledge raising regarding cervical cancer.
  • Mint⁺: ABC HEALTH LABO
  • 5 articles including "Preconception Care for Your Own and Your Family's Health Starting Today" (average monthly users: approx. 300,000 / PV: approx. 400,000)
S: Contribution to animal health
Company-wide Action Plan
Contribution to creation of a society where people and animals can coexist
SDGs
     
KPIs 1st half of FY2023 activity report
Promotion of animal welfare
  • Shonan Research Center Initiatives
  • 1. Disclose ethical considerations in research on the Company's website (continued)
  • 2. Conducted animal experiments at AAALAC-certified facilities in compliance with company regulations and Shonan iPark's animal experimentation rules. (continued) 
    3. Participated in the animal memorial service at Shonan iPark on September 12 (Tue.)
  • Animal Health Initiatives
  • 1. Participated in the academic societies (WJVF/JBVP) that promote "animal welfare" as a corporate sponsor and exhibitor.
    WJVF: Total of 1,494 people including veterinarians, pet nurses and students, etc. participated on July 8-9, 2023
    JBVP: Total of 2,806 people including veterinarians, pet nurses, students, and citizens, etc. participated on September 23-24, 2023
  • 2. THYLOBLOCK Tablets (for the treatment of feline hyperthyroidism):.
        GPSP (122 cases/efficacy rate 97%) "Interim Analysis Report" submitted by Ministry of Agriculture, Forestry and Fisheries
  • 3. Trilostane tablets "ASKA" (for treatment of canine hyperadrenocorticism): 
     (1) Distribution of scientific materials (20,000 copies)
     (2) Briefing sessions for distributors, veterinary hospitals, and handling of various other inquiries, etc.
Development and provision of products useful for maintaining the health of companion animals
  • Provided information to raise awareness of endocrine disorders through THYLOBLOCK tablets and trilostane tablets "ASKA".
  • Promote the development of therapeutic agents for companion animal diseases
    (Started formulation design of one new formulation)
Development and provision of non-invasive measurement kit products using body hair
  • Clinical trials are underway using feline body hair to measure hormones for early detection of disease.
Promotion of biodiversity
  • Promoted a biodiverse environment by providing a diverse range of products that target animals, including livestock, pets, and aquatic creatures.